Relay Therapeutics, Inc.
RLAY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $124 | $144 | $999 | $280 |
| Short-Term Investments | $657 | $606 | $0 | $678 |
| Receivables | $0 | $0 | $5 | $5 |
| Inventory | $0 | $0 | $12 | $0 |
| Other Curr. Assets | $28 | $20 | $3 | $13 |
| Total Curr. Assets | $809 | $770 | $1,020 | $976 |
| Property Plant & Equip (Net) | $58 | $69 | $75 | $27 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $2 | $2 |
| Long-Term Investments | $0 | $3 | $3 | $0 |
| Tax Assets | $0 | $0 | -$3 | $0 |
| Other NC Assets | $2 | $0 | $3 | $3 |
| Total NC Assets | $62 | $74 | $80 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $871 | $844 | $1,100 | $1,008 |
| Liabilities | – | – | – | – |
| Payables | $14 | $9 | $11 | $8 |
| Short-Term Debt | $6 | $5 | $4 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $8 | $0 | $0 | $0 |
| Other Curr. Liab. | $23 | $16 | $49 | $14 |
| Total Curr. Liab. | $51 | $30 | $64 | $24 |
| LT Debt | $43 | $49 | $53 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $13 | $32 | $65 |
| Total NC Liab. | $43 | $62 | $86 | $86 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $49 | $53 | $58 | $23 |
| Total Liabilities | $94 | $92 | $150 | $111 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,738 | -$1,401 | -$1,059 | -$768 |
| AOCI | -$1 | -$0 | -$10 | -$1 |
| Other Equity | $2,517 | $2,153 | $2,019 | $1,667 |
| Total Equity | $778 | $752 | $950 | $898 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $871 | $844 | $1,100 | $1,008 |
| Net Debt | -$76 | -$90 | -$941 | -$257 |